ASO Author Reflections: Which was the Better Regimen (Gemcitabine Plus Nab-Paclitaxel Versus Gemcitabine Plus S-1) as Neoadjuvant Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma (R/BR-PDAC)?

期刊论文
发表日期：

2024年5月9日

查看全文

Daisaku Yamada,
Shogo Kobayashi,
Hidenori Takahashi,
Yoshifumi Iwagami,
Hirofumi Akita,
Kei Asukai,
Junzo Shimizu,
Terumasa Yamada,
Masahiro Tanemura,
Shigekazu Yokoyama,
Masanori Tsujie,
Tadafumi Asaoka,
Yutaka Takeda,
Osakuni Morimoto,
Akira Tomokuni,
Yuichiro Doki,
Hidetoshi Eguchi

本文未提供摘要，请点击“查看全文”查看完整内容。